- Home
- GSK vs SCCO Comparison
GSK vs SCCO Comparison
Compare GSK & SCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- SCCO
- Stock Information
- Founded
- GSK 1715
- SCCO 1952
- Country
- GSK United Kingdom
- SCCO United States
- Employees
- GSK N/A
- SCCO N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- SCCO Metal Mining
- Sector
- GSK Health Care
- SCCO Basic Materials
- Exchange
- GSK Nasdaq
- SCCO Nasdaq
- Market Cap
- GSK 81.9B
- SCCO 82.0B
- IPO Year
- GSK N/A
- SCCO N/A
- Fundamental
- Price
- GSK $43.65
- SCCO $133.44
- Analyst Decision
- GSK Hold
- SCCO Hold
- Analyst Count
- GSK 2
- SCCO 7
- Target Price
- GSK N/A
- SCCO $112.76
- AVG Volume (30 Days)
- GSK 5.9M
- SCCO 2.2M
- Earning Date
- GSK 10-29-2025
- SCCO 10-24-2025
- Dividend Yield
- GSK 3.71%
- SCCO 2.38%
- EPS Growth
- GSK N/A
- SCCO 31.70
- EPS
- GSK 1.13
- SCCO 4.48
- Revenue
- GSK $43,336,073,439.00
- SCCO $11,888,200,000.00
- Revenue This Year
- GSK $5.50
- SCCO $8.26
- Revenue Next Year
- GSK $5.21
- SCCO N/A
- P/E Ratio
- GSK $38.60
- SCCO $29.73
- Revenue Growth
- GSK 0.59
- SCCO 13.01
- 52 Week Low
- GSK $31.72
- SCCO $73.44
- 52 Week High
- GSK $45.59
- SCCO $136.50
- Technical
- Relative Strength Index (RSI)
- GSK 62.67
- SCCO 70.38
- Support Level
- GSK $43.10
- SCCO $125.06
- Resistance Level
- GSK $44.23
- SCCO $136.50
- Average True Range (ATR)
- GSK 0.88
- SCCO 3.93
- MACD
- GSK 0.07
- SCCO 0.50
- Stochastic Oscillator
- GSK 69.13
- SCCO 85.78
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About SCCO Southern Copper Corporation
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. It generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. The company's geographical segments are The Americas, Europe, and Asia.